← Open Payments lookup

ERIKA PINTO: Open Payments

NPI 1164977013 · BERLIN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,974 in 125 payments from 18 companies in 2025. Trend: 2023 $2,126 · 2024 $3,048 · 2025 $2,974

Food & beverage: $2,974
CompanyPaymentsAmount
ABBVIE INC.28$761
Janssen Biotech, Inc.14$469
QOL Medical, LLC17$391
Takeda Pharmaceuticals U.S.A., Inc.10$227
Phathom Pharmaceuticals, Inc.13$170
Salix Pharmaceuticals, a division of Bausch Health US, LLC7$162
GENZYME CORPORATION6$151
Regeneron Healthcare Solutions, Inc.7$149
Ardelyx, Inc.4$79
PFIZER INC.4$65

Products named: TREMFYA, Sucraid, DUPIXENT, MAVYRET, SKYRIZI, ENTYVIO, VOQUEZNA, XIFAXAN.

Industry payments across MD — which companies pay providers there.